AI summary Trust: medium Third-party lab

This COA was tested by an independent third-party lab, LabE. The report indicates 99.95% purity for Tirzepatide batch G20250542 via HPLC and mass quantification. Quantity showed a significant deviation of -12.4% from the 20mg label. Endotoxin status and test recency are unknown. Customers can cross-check on the lab's public verification URL.

Watch out for
  • no endotoxin test
  • stale (8+ months)
  • quantity deviation (-12.4%)
Test date
—
Purity
99.95% 99.95%
Batch / lot
[NAME_REDACTED]
Lab
LabE
Quantity
label 20mg tested 20.1mg
Qty vs label
+0.5%
-12.4% vs vendor claim
Endotoxins
—
Test score
7.4
Manufacturer
GYC
View vendor dossier
Certificate

Test report image

Certificate scan
Certificate scan as published.
Source

Finnrick

✓ Artifact captured

We have the certificate image (SHA-256 hash captured) — you can verify it loads from the upstream lab and matches the artifact below.

Verify on upstream
Method
HPLC + mass quantification + endotoxins
Test type
finnrick_composite
Dose
20mg
Container
No Label / Copper Crimp / Clear Cap
Catalogued
2026-04-16
Artifact hash
1ebc987ee994c5e4…
This COA is part of TitrateLab's community-trust corpus. See more from GYC or learn how trust scores are computed on the methodology page.